|
Generics |
|
 |
Lupin Pharmaceuticals, Inc. entered the U.S. generic pharmaceutical market in 2003 with the ANDA approval for cefuroxime axetil. Since then we have received more than a dozen FDA approvals.
Find out
More |
| |
|
| |
|
Specialty |
|
 |
Lupin Pharmaceuticals, Inc., is very pleased to offer Suprax®, an
important anti-infective product in pediatric and other physician
practices within the United States. Suprax® is now available in
tablets and suspension formulations. Lupin Pharmaceuticals, Inc.,
has an exclusive license in the United States to use the Suprax®
trademark.
Find out
More |
| |
|
| |
|
API |
|
 |
Lupin is recognized as a leading manufacturer of cephalosporin API’s, with FDA approval to manufacture complex oral and injectable cephalosporins.
Find out
More |
